{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:02Z","timestamp":1793600822538,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371776"],"award-info":[{"award-number":["82371776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171753"],"award-info":[{"award-number":["82171753"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301992"],"award-info":[{"award-number":["82301992"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015976","name":"State Key Laboratory of Pathogen and Biosecurity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015976","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2021ZD0201600"],"award-info":[{"award-number":["2021ZD0201600"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.neuropharm.2026.110950","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:55:38Z","timestamp":1774367738000},"page":"110950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel mechanism of hypidone hydrochloride (YL-0919) in Parkinson's disease: inhibiting neuronal ferroptosis by targeting the Sigma1R-PI3K-AKT-ACSL4 axis"],"prefix":"10.1016","volume":"292","author":[{"given":"Mengying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junrui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9547-1838","authenticated-orcid":false,"given":"Yuxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gencheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110950_bib1","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.4103\/NRR.NRR-D-23-01424","article-title":"Hypidone hydrochloride (YL-0919) ameliorates functional deficits after traumatic brain injury in mice by activating the sigma-1 receptor for antioxidation","volume":"20","author":"Bai","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2026.110950_bib2","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2026.110950_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.freeradbiomed.2022.12.086","article-title":"ACSL4 and the lipoxygenases 15\/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons","volume":"195","author":"Bouchaoui","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2026.110950_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuropharm.2017.10.032","article-title":"Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders","volume":"128","author":"Bruns","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110950_bib5","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00018-020-03679-5","article-title":"New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis","volume":"78","author":"Castillo","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2026.110950_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108373","article-title":"Molecular mechanisms of ferroptosis and their involvement in brain diseases","volume":"244","author":"Costa","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2026.110950_bib7","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s42003-023-05272-5","article-title":"Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease","volume":"6","author":"Dai","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson's disease","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.neuropharm.2026.110950_bib9","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","article-title":"Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism","volume":"136","author":"Ding","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.neuropharm.2026.110950_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102077","article-title":"Ferroptosis in Parkinson's disease: molecular mechanisms and therapeutic potential","volume":"91","author":"Ding","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2026.110950_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111524","article-title":"Hypidone hydrochloride (YL-0919) protects mice from meningitis via Sigma1R-STAT1-NLRP3-GSDMD pathway","volume":"128","author":"Gao","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.freeradbiomed.2024.07.018","article-title":"Acteoside alleviates lipid peroxidation by enhancing Nrf2-mediated mitophagy to inhibit ferroptosis for neuroprotection in Parkinson's disease","volume":"223","author":"Han","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2026.110950_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.gaitpost.2023.01.022","article-title":"Dopamine replacement therapy normalizes reactive step length to postural perturbations in Parkinson's disease","volume":"101","author":"Herbers","year":"2023","journal-title":"Gait Posture"},{"key":"10.1016\/j.neuropharm.2026.110950_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1471-4159.1991.tb08170.x","article-title":"Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis","volume":"56","author":"Hirsch","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110950_bib15","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1007\/s12035-023-03713-0","article-title":"TREM2 deficiency aggravates NLRP3 inflammasome activation and pyroptosis in MPTP-Induced Parkinson's disease mice and LPS-induced BV2 cells","volume":"61","author":"Huang","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210021","article-title":"ACSL4-Mediated ferroptosis and its potential role in central nervous system diseases and injuries","volume":"24","author":"Jia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110950_bib17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/ene.14607","article-title":"Biological fluid levels of iron and iron-related proteins in parkinson's disease: review and meta-analysis","volume":"28","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233736","article-title":"Levodopa-induced dyskinesia in Parkinson's Disease: pathogenesis and emerging treatment strategies","volume":"11","author":"Kwon","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2026.110950_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70027","article-title":"Exosome-derived CDC42 from hypoxia-pretreated neural stem cells inhibits ACSL4-Related ferroptosis to alleviate vascular injury in Parkinson's Disease mice models","volume":"169","author":"Li","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110950_bib20","first-page":"57","article-title":"Preparation and assessment of a C57BL\/6 mouse Parkinson's model induced by MPTP","volume":"30","author":"Lin","year":"2020","journal-title":"Chin. J. Comp. Med."},{"key":"10.1016\/j.neuropharm.2026.110950_bib21","article-title":"Anti-PTSD effects of hypidone hydrochloride (YL-0919): a novel combined selective 5-HT reuptake Inhibitor\/5-HT(1A) receptor partial Agonist\/5-HT(6) receptor full agonist","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.648636","article-title":"PI3K\/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer's Disease and Parkinson's Disease","volume":"12","author":"Long","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101890","article-title":"Ferroptosis and its potential role in the physiopathology of Parkinson's Disease","volume":"196","author":"Mahoney-S\u00e1nchez","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib24","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1002\/ptr.8342","article-title":"Role of glutathione in Parkinson's Disease pathophysiology and therapeutic potential of polyphenols","volume":"38","author":"Niu","year":"2024","journal-title":"Phytother Res."},{"key":"10.1016\/j.neuropharm.2026.110950_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/aps.2017.83","article-title":"YL-0919, a dual 5-HT(1A) partial agonist and SSRI, produces antidepressant- and anxiolytic-like effects in rats subjected to chronic unpredictable stress","volume":"39","author":"Ran","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2026.110950_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175647","article-title":"Sigma-1 receptor agonist properties that mediate the fast-onset antidepressant effect of hypidone hydrochloride (YL-0919)","volume":"946","author":"Ren","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.tips.2023.07.007","article-title":"Therapeutic inhibition of ferroptosis in neurodegenerative disease","volume":"44","author":"Ryan","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110950_bib28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12035-016-0342-0","article-title":"Neuroprotective effects of antidepressants via upregulation of neurotrophic factors in the MPTP model of Parkinson's Disease","volume":"55","author":"Shadfar","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib29","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1021\/acschemneuro.3c00717","article-title":"Glutathione depletion and concomitant elevation of susceptibility in patients with Parkinson's Disease: state-of-the-art MR spectroscopy and neuropsychological study","volume":"14","author":"Shukla","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110950_bib30","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1474-4422(22)00400-8","article-title":"Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial","volume":"21","author":"Soileau","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib32","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","article-title":"Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway","volume":"91","author":"Sun","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.110950_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2024.124590","article-title":"Silica nanoparticles induce liver lipid metabolism disorder via ACSL4-mediated ferroptosis","volume":"359","author":"Sun","year":"2024","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.neuropharm.2026.110950_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.110950_bib35","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s13311-023-01382-4","article-title":"Inhibition of ACSL4 alleviates parkinsonism phenotypes by reduction of lipid reactive oxygen species","volume":"20","author":"Tang","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2026.110950_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1413520","article-title":"Mogroside V and mogrol: unveiling the neuroprotective and metabolic regulatory roles of Siraitia grosvenorii in Parkinson's disease","volume":"15","author":"Tang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib37","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson's disease","volume":"391","author":"Tanner","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2026.110950_bib38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib39","article-title":"Targeting ferroptosis: acteoside as a neuroprotective agent in Salsolinol-Induced Parkinson's Disease models","volume":"30","author":"Wang","year":"2025","journal-title":"Front. Biosci."},{"key":"10.1016\/j.neuropharm.2026.110950_bib40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.freeradbiomed.2024.02.023","article-title":"Neuroprotective effects of cordycepin on MPTP-induced Parkinson's disease mice via suppressing PI3K\/AKT\/mTOR and MAPK-mediated neuroinflammation","volume":"216","author":"Wang","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2026.110950_bib41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cell.2024.10.047","article-title":"ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.110950_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102035","article-title":"Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases","volume":"91","author":"Wang","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2026.110950_bib43","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","article-title":"Ferroptosis in Parkinson's disease: glia-neuron crosstalk","volume":"28","author":"Wang","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.110950_bib45","first-page":"43","article-title":"Stem-leaf saponins of Panax notoginseng attenuate experimental Parkinson's disease progression in mice by inhibiting microglia-mediated neuroinflammation via P2Y2R\/PI3K\/AKT\/NF\u03baB signaling pathway","volume":"23","author":"Wu","year":"2025","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.neuropharm.2026.110950_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154250","article-title":"Artemisia leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy\/mitophagy clearance in both in vitro and in vivo models of MPP+\/MPTP-induced Parkinson's disease","volume":"104","author":"Wu","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2026.110950_bib47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/JS9.0000000000002081","article-title":"Translational evaluation of metabolic risk factors impacting DBS efficacy for PD-related sleep and depressive disorders: preclinical, prospective and cohort studies","volume":"111","author":"Yao","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.neuropharm.2026.110950_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303711","article-title":"LRRK2 Gly2019Ser mutation promotes ER stress via interacting with THBS1\/TGF-\u03b21 in Parkinson's Disease","volume":"10","author":"Yao","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.neuropharm.2026.110950_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12974-018-1053-4","article-title":"MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease","volume":"15","author":"Yao","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.110950_bib50","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1096\/fj.201900363R","article-title":"MicroRNA-124 regulates the expression of p62\/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease","volume":"33","author":"Yao","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2026.110950_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102477","article-title":"Ferroptosis in Parkinson's disease -- the iron-related degenerative disease","volume":"101","author":"Yao","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2026.110950_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117628","article-title":"Piperine promotes PI3K\/AKT\/mTOR-mediated gut-brain autophagy to degrade \u03b1-Synuclein in Parkinson's disease rats","volume":"322","author":"Yu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41556-021-00818-3","article-title":"PKC\u03b2II phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis","volume":"24","author":"Zhang","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2026.110950_bib54","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/aps.2017.49","article-title":"Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease","volume":"38","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2026.110950_bib55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/CM9.0000000000003400","article-title":"Neuroprotective effects of hypidone hydrochloride (YL-0919) after traumatic brain injury in mice","volume":"139","author":"Zhang","year":"2025","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.neuropharm.2026.110950_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104538","article-title":"Caffeic acid reduces A53T \u03b1-synuclein by activating JNK\/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease","volume":"150","author":"Zhang","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2026.110950_bib57","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00031.2024","article-title":"Ferroptosis: when metabolism meets cell death","volume":"105","author":"Zheng","year":"2025","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2026.110950_bib58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41401-021-00635-2","article-title":"Mitochondrial aldehyde dehydrogenase (ALDH2) rescues cardiac contractile dysfunction in an APP\/PS1 murine model of Alzheimer's disease via inhibition of ACSL4-dependent ferroptosis","volume":"43","author":"Zhu","year":"2022","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:34:09Z","timestamp":1793597649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826001231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":56,"alternative-id":["S0028390826001231"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110950","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel mechanism of hypidone hydrochloride (YL-0919) in Parkinson's disease: inhibiting neuronal ferroptosis by targeting the Sigma1R-PI3K-AKT-ACSL4 axis","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110950"}}